Maternal and Child Health Practice Questions

Q: Which of the following is a second-generation Intrauterine Device (IUD)?

CuT-200. **Explanation:** Intrauterine Devices (IUDs) are classified into three generations based on their composition and mechanism of action. Understanding this classification is high-yield for NEET-PG. **Why CuT-200 is correct:** **CuT-200** belongs to the **Second Generation IUDs**, which are characterized by the addition of **copper** to a plastic (polyethylene) frame. Copper acts as a spermicide by causing a local inflammatory response in the endometrium and altering cervical mucus. The "200" represents the surface area of copper in square millimeters. Other examples include CuT-380A, Multiload (MLCu-250/375), and Nova T. **Analysis of Incorrect Options:** * **Lippes Loop (Option D):** This is a **First Generation IUD**. These are non-medicated, inert devices usually made of polyethylene or stainless steel. They are rarely used today due to higher expulsion and failure rates. * **Progestasert and Mirena (Options A & B):** These are **Third Generation IUDs** (Hormone-releasing IUDs). * **Progestasert** releases Progesterone (first-generation hormonal IUD). * **Mirena** (LNG-20) releases Levonorgestrel and is the most commonly used hormonal IUD today. **Clinical Pearls for NEET-PG:** * **Ideal Candidate:** Multiparous women in a stable monogamous relationship. * **Mechanism of Action:** Primarily prevents fertilization by being gametotoxic (especially copper IUDs). * **Most Common Side Effect:** Excessive menstrual bleeding (menorrhagia) is the #1 reason for removal. * **Most Common Complication:** Pain. * **CuT-380A:** Currently the most effective copper IUD with a lifespan of **10 years**.

Q: What is the most common cause of neonatal mortality?

Prematurity. **Explanation:** **1. Why Prematurity is the Correct Answer:** According to the latest global and national (India) health statistics (including WHO and SRS data), **Prematurity and Low Birth Weight (LBW)** are the leading causes of neonatal mortality, accounting for approximately **35-45%** of all neonatal deaths. Premature infants are highly vulnerable due to anatomical and physiological immaturity, leading to fatal complications such as Respiratory Distress Syndrome (RDS), Intraventricular Hemorrhage (IVH), and Necrotizing Enterocolitis (NEC). **2. Analysis of Incorrect Options:** * **Infection (Sepsis):** While neonatal sepsis, pneumonia, and meningitis are significant contributors (the second leading cause globally), they have been surpassed by prematurity due to improved antibiotic protocols and institutional delivery practices. * **Birth Injuries:** These (along with Birth Asphyxia) are the third most common cause. While critical, they occur less frequently than complications arising from preterm birth. * **Diarrhea:** While a major cause of mortality in the **post-neonatal period** (1 month to 5 years), it is a rare cause of death in the first 28 days of life. **3. NEET-PG High-Yield Pearls:** * **Neonatal Period:** Defined as the first 28 days of life. * **Early Neonatal Mortality:** Deaths within the first 7 days; the most common cause is **Prematurity**. * **Late Neonatal Mortality:** Deaths between 7 to 28 days; the most common cause is **Infection**. * **Under-5 Mortality (India):** The leading cause is also **Prematurity**, followed by Pneumonia. * **Most common cause of LBW in India:** Intrauterine Growth Restriction (IUGR) due to maternal malnutrition.

Q: What is the definition of Maternal Mortality Rate?

None of the above. The correct answer is **None of the above** because the options provided confuse the definitions of Maternal Mortality Rate (MMR) and Maternal Mortality Ratio (MMR). ### 1. Understanding the Medical Concept In public health, there is a critical distinction between "Rate" and "Ratio": * **Maternal Mortality Ratio:** This is the most commonly used indicator. It is defined as the number of maternal deaths per **100,000 live births**. It measures the obstetric risk once a woman becomes pregnant. * **Maternal Mortality Rate:** This is defined as the number of maternal deaths in a given period per **1,000 women of reproductive age (15–49 years)**. It reflects both the risk of maternal death per pregnancy and the frequency with which women are exposed to that risk (fertility). ### 2. Why the other options are wrong * **Options A & C:** These use "births" (which includes stillbirths) as the denominator. Standard maternal mortality indicators typically use "live births" or the "female population of reproductive age." * **Option B:** This describes a proportion (per 100 live births), but the standard multiplier for the Maternal Mortality Ratio is **100,000**, not 100. ### 3. High-Yield NEET-PG Pearls * **Denominator Trap:** Always check if the question asks for *Ratio* (Denominator: Live Births) or *Rate* (Denominator: Women aged 15-49). * **Maternal Death Definition:** Death of a woman while pregnant or within **42 days** of termination of pregnancy, irrespective of the duration and site of the pregnancy. * **Most Common Cause:** In India, the leading cause of maternal mortality is **Obstetric Hemorrhage** (specifically Postpartum Hemorrhage/PPH). * **Current Target:** The Sustainable Development Goal (SDG) target 3.1 aims to reduce the global maternal mortality ratio to less than **70 per 100,000 live births** by 2030.

Q: The perinatal period corresponds to which of the following timeframes?

28 weeks of gestation to 7 days after birth. The **perinatal period** is a critical transition phase in human development. According to the World Health Organization (WHO) and standard pediatric textbooks (like Ghai Pediatrics), it is defined as the period starting from **28 weeks of gestation** (when the fetus is considered viable in many developing regions) and ending at **7 completed days after birth**. ### **Why Option A is Correct** This definition captures the late fetal period and the early neonatal period. It is used globally to calculate the **Perinatal Mortality Rate (PMR)**, which is a key indicator of the quality of antenatal, obstetric, and neonatal care. ### **Analysis of Incorrect Options** * **Option B:** "Period of labor" is too narrow. The perinatal period must include a significant portion of late gestation to account for stillbirths. * **Option C:** The "Third trimester" begins at 24–26 weeks, which is slightly earlier than the standard 28-week cutoff used for this specific definition. * **Option D:** 36 weeks is too late; many complications (like preterm labor) that contribute to perinatal mortality occur well before this timeframe. ### **High-Yield Clinical Pearls for NEET-PG** * **Early Neonatal Period:** 0 to 7 days of life. * **Late Neonatal Period:** 7 to 28 days of life. * **Neonatal Period:** Birth to 28 days. * **Infancy:** Birth to 1 year. * **Perinatal Mortality Rate Formula:** (Late fetal deaths [>28 weeks] + Early neonatal deaths [0-7 days]) / (Total Live Births + Stillbirths) × 1000. * **Note:** In developed countries, the perinatal period may be defined as starting at 22 weeks (500g birth weight), but for Indian exams, **28 weeks** remains the standard benchmark.

Q: What is the iron content of the MALA-D contraceptive?

19.5 mg. **Explanation:** Mala-D is a Combined Oral Contraceptive Pill (COCP) provided under the National Family Welfare Programme in India. Each cycle pack contains **28 tablets**: 21 hormonal (active) tablets and 7 non-hormonal (placebo) tablets. **1. Why 19.5 mg is correct:** The 7 brown-colored placebo tablets in the Mala-D pack are not empty; they contain **Ferrous Fumarate**. Each of these 7 tablets contains **60 mg of Ferrous Fumarate**, which provides exactly **19.5 mg of elemental iron**. This is included to maintain the habit of daily pill-taking and to supplement iron stores, as many women in the reproductive age group in India suffer from iron-deficiency anemia due to menstrual blood loss. **2. Analysis of Incorrect Options:** * **10 mg:** This is a distracter and does not correspond to standard iron formulations in OCPs. * **29.5 mg:** This is often confused with the elemental iron content of other supplements. * **40 mg:** While some therapeutic iron doses are higher, the standard prophylactic dose in Mala-D remains 19.5 mg elemental iron. **3. High-Yield Clinical Pearls for NEET-PG:** * **Composition of Active Pill:** 0.15 mg Levonorgestrel + 0.03 mg Ethinyl Estradiol. * **Mala-N vs. Mala-D:** Both have the same composition. The only difference is that **Mala-N is free** of cost at government centers, while **Mala-D is subsidized** (social marketing). * **Centchroman (Chhaya):** A non-steroidal, once-a-week pill (Selective Estrogen Receptor Modulator). * **Failure Rate:** The Pearl Index of COCPs with perfect use is 0.1 per 100 woman-years.

Q: Integrated Management of Childhood Illness (IMCI) guidelines include management of all the following conditions EXCEPT:

Tuberculosis (TB). ### Explanation The **Integrated Management of Childhood Illness (IMCI)** strategy, developed by WHO and UNICEF, is designed to reduce global child mortality by focusing on the most common causes of death in children under five years of age. **Why Tuberculosis (TB) is the Correct Answer:** IMCI focuses on the **syndromic management** of acute, life-threatening conditions that require immediate intervention at the primary health care level. While TB is a significant pediatric health issue, it is a **chronic infection** requiring specialized diagnostic tools (like gastric lavage or CBNAAT) and long-term treatment protocols under the National Tuberculosis Elimination Program (NTEP). Therefore, it is not included in the standard IMCI management algorithms for acute childhood illnesses. **Analysis of Incorrect Options:** * **Acute Respiratory Infections (ARI):** IMCI classifies ARI (specifically Pneumonia) based on respiratory rate and chest indrawing. It is a core component because it is a leading cause of child mortality. * **Malaria:** In endemic areas, IMCI includes protocols for assessing and treating fever, with specific algorithms for Malaria based on blood smears or RDTs. * **Diarrhea:** IMCI provides comprehensive guidelines for assessing dehydration levels and managing diarrhea using ORS and Zinc, as it is a major cause of preventable death. **High-Yield Clinical Pearls for NEET-PG:** * **Age Group:** IMCI covers two groups: **0–2 months** (Young Infants) and **2 months–5 years**. * **The "Big Five":** IMCI primarily targets **Pneumonia, Diarrhea, Malaria, Measles, and Malnutrition** (including Anemia). * **Color Coding:** IMCI uses a "Triage" system: **Pink** (Urgent referral), **Yellow** (OPD treatment), and **Green** (Home management). * **IMNCI (India):** In India, "Neonatal" was added (IMNCI) to include care for the first 0–28 days of life, emphasizing home-based newborn care.

Q: Maximum maternal mortality during the peripartum period occurs at which stage?

Immediate postpartum. **Explanation:** The **immediate postpartum period** (the first 24 to 48 hours after delivery) is the most critical window for maternal survival. The primary reason for this is **Postpartum Hemorrhage (PPH)**, which is the leading cause of maternal mortality worldwide and in India. During this stage, the sudden hemodynamic shift and the risk of uterine atony can lead to rapid, life-threatening blood loss. Additionally, conditions like amniotic fluid embolism and eclampsia-related complications frequently peak during or immediately after delivery. **Analysis of Options:** * **Last Trimester (A):** While risks like Pre-eclampsia and Antepartum Hemorrhage (APH) exist, they are generally manageable with timely intervention and rarely cause the volume of sudden deaths seen during delivery. * **During Labor (B):** Although labor is high-risk due to potential rupture or distress, the most fatal complications (like massive PPH) typically manifest immediately after the placenta is expelled. * **Delayed Postpartum (D):** This period (after 48 hours up to 42 days) carries risks like puerperal sepsis and secondary PPH, but these are usually slower in progression and less frequently fatal compared to the hyper-acute events of the first 24 hours. **High-Yield NEET-PG Pearls:** * **The "Big Three" causes of Maternal Mortality:** Hemorrhage (most common), Sepsis, and Hypertensive disorders. * **Timeframe:** Approximately 50-70% of maternal deaths occur in the postpartum period; of these, the majority occur within the first 24 hours. * **Public Health Strategy:** This is why "Active Management of the Third Stage of Labor" (AMTSL) and institutional deliveries are prioritized in programs like JSY and JSSK to reduce MMR.

Q: Maternal mortality rate is calculated based on deaths occurring up to what period after delivery?

42 days after delivery. **Explanation:** The correct answer is **42 days after delivery (Option B)**. This definition is standardized by the World Health Organization (WHO) and the International Classification of Diseases (ICD). **Why it is correct:** A maternal death is defined as the death of a woman while pregnant or within **42 days (6 weeks)** of termination of pregnancy, irrespective of the duration and site of the pregnancy. This period corresponds to the **puerperium**, during which the body undergoes physiological reversal to the non-pregnant state. Deaths included must be from any cause related to or aggravated by the pregnancy or its management, but not from accidental or incidental causes. **Why other options are incorrect:** * **Option A (Immediately):** This would only account for intrapartum deaths (e.g., amniotic fluid embolism or acute hemorrhage), missing the majority of postpartum complications like sepsis or secondary PPH. * **Option C (7 days):** This represents the "early neonatal period" for infants, but for mothers, many life-threatening complications (like puerperal sepsis) often manifest after the first week. * **Option D (21 days):** This is an arbitrary timeframe with no clinical or statistical significance in maternal health monitoring. **High-Yield NEET-PG Pearls:** * **Maternal Mortality Ratio (MMR):** Calculated per **100,000 live births**. It measures the obstetric risk. (Note: It is a *ratio*, not a true *rate*). * **Maternal Mortality Rate:** Calculated per 1,000 women of reproductive age (15-49 years). * **Late Maternal Death:** Death occurring more than 42 days but less than **one year** after termination of pregnancy. * **Most common cause of Maternal Mortality in India:** Obstetric Hemorrhage (specifically Postpartum Hemorrhage/PPH). * **SDG Target 3.1:** Reduce the global MMR to less than **70 per 100,000 live births** by 2030.

Q: What is the ideal number of antenatal visits recommended?

4. The correct answer is **A (4)**. ### **Explanation** The "Ideal" number of antenatal visits is a frequently tested concept in NEET-PG, often leading to confusion between WHO and National guidelines. 1. **Why Option A is Correct:** According to the **WHO (Focussed Antenatal Care model)** and the **Ministry of Health and Family Welfare (MoHFW), India**, the minimum recommended number of antenatal visits for a healthy pregnant woman is **4**. These are scheduled as follows: * **1st Visit:** Within 12 weeks (Registration/First trimester). * **2nd Visit:** Between 14–26 weeks (Second trimester). * **3rd Visit:** Between 28–34 weeks (Third trimester). * **4th Visit:** Between 36 weeks and term. 2. **Why Other Options are Incorrect:** * **Option B (8):** In 2016, the WHO updated its "Antenatal Care Model" to recommend a minimum of **8 contacts** to reduce perinatal mortality. However, in the context of standard Indian guidelines and traditional NEET-PG questions, **4** remains the "ideal minimum" unless "WHO 2016 guidelines" are specifically mentioned. * **Options C & D:** These do not correspond to any standard global or national protocol for routine antenatal care. ### **High-Yield Clinical Pearls for NEET-PG** * **Pradhan Mantri Surakshit Matritva Abhiyan (PMSMA):** Conducted on the **9th of every month** to ensure at least one check-up by a specialist. * **Weight Gain:** Average weight gain during pregnancy is **11 kg**. * **Tetanus Prophylaxis:** Two doses of Td (Tetanus-diphtheria) are given; the first at registration and the second 4 weeks later. If the woman was immunized within the last 3 years, only one **booster dose** is required. * **Iron-Folic Acid (IFA):** 100mg elemental iron and 500mcg folic acid for 180 days (starting from the second trimester).

Q: ASHA workers are not depot holders of which of the following?

Oral Polio Vaccine (OPV). **Explanation:** The core concept behind this question is the **Cold Chain requirement**. ASHA (Accredited Social Health Activist) workers are community-based volunteers who act as "depot holders" for essential health commodities that can be stored at room temperature. **Why Oral Polio Vaccine (OPV) is the correct answer:** OPV is highly heat-sensitive and must be maintained in a strict cold chain (stored at +2°C to +8°C at the PHC level and -20°C at the district level). ASHA workers do not possess the infrastructure (like ILRs or deep freezers) to maintain this cold chain. Therefore, vaccines are never "stocked" by ASHAs; they are only transported in vaccine carriers during immunization days (RI/Pulse Polio). **Analysis of incorrect options:** * **ORS & IFA Tablets:** These are essential life-saving commodities for managing diarrhea and anemia, respectively. They are stable at room temperature and are part of the standard **ASHA Drug Kit** to ensure immediate community access. * **Contraceptives:** ASHAs are primary providers for the "Home Delivery of Contraceptives" scheme. They hold stocks of condoms, Oral Contraceptive Pills (Mala-N), and Emergency Contraceptive Pills (ECP) to promote family planning. **High-Yield Clinical Pearls for NEET-PG:** * **ASHA Kit Contents:** Includes ORS, IFA (Large & Small), Chloroquine, Paracetamol, DDK (Disposable Delivery Kits), and Contraceptives. * **New Additions:** ASHAs are now also depot holders for **Pregnancy Test Kits (Nishchay)** and **Rapid Diagnostic Kits (RDK)** for Malaria. * **Population Norm:** 1 ASHA per 1,000 population (Plain areas) and 1 per habitation (Tribal/Hilly areas). * **Incentive:** ASHAs are not salaried but receive performance-linked incentives (e.g., for JSY, immunization, and TB referral).

Question 1

Which of the following is a second-generation Intrauterine Device (IUD)?

Accepted Answer

CuT-200

Answer

Progestasert

Answer

Mirena

Answer

Lippes Loop

Question 2

What is the most common cause of neonatal mortality?

Accepted Answer

Prematurity

Answer

Birth injuries

Answer

Infection

Answer

Diarrhea

Question 3

What is the definition of Maternal Mortality Rate?

Accepted Answer

None of the above

Answer

Maternal death per 100 births

Answer

Maternal death per 100 live births

Answer

Maternal death per 1000 births

Question 4

The perinatal period corresponds to which of the following timeframes?

Accepted Answer

28 weeks of gestation to 7 days after birth

Answer

Period of labor to newborn period

Answer

Third trimester of pregnancy to newborn period

Answer

36 weeks of gestation to 3 days after birth

Question 5

What is the iron content of the MALA-D contraceptive?

Accepted Answer

19.5 mg

Answer

10 mg

Answer

29.5 mg

Answer

40 mg

Question 6

Integrated Management of Childhood Illness (IMCI) guidelines include management of all the following conditions EXCEPT:

Accepted Answer

Tuberculosis (TB)

Answer

Acute Respiratory Infections (ARI)

Answer

Malaria

Answer

Diarrhea

Question 7

Maximum maternal mortality during the peripartum period occurs at which stage?

Accepted Answer

Immediate postpartum

Answer

Last trimester

Answer

During labor

Answer

Delayed postpartum

Question 8

Maternal mortality rate is calculated based on deaths occurring up to what period after delivery?

Accepted Answer

42 days after delivery

Answer

Immediately after delivery

Answer

7 days after delivery

Answer

21 days after delivery

Question 9

What is the ideal number of antenatal visits recommended?

Accepted Answer

4

Answer

8

Answer

6

Answer

10

Question 10

ASHA workers are not depot holders of which of the following?

Accepted Answer

Oral Polio Vaccine (OPV)

Answer

Oral Rehydration Salts (ORS)

Answer

Iron and Folic Acid (IFA) tablets

Answer

Contraceptives

Maternal and Child Health — MCQs

Maternal and Child Health — MCQs

On this page

Practice by Chapter

Want unlimited practice?